20 Sep 2023 , 10:15 AM
According to two sources in the know, India’s Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to get a loan of up to $1 billion to assist in supporting a planned bid for Cipla.
According to sources, Torrent is trying to acquire $3 billion to $4 billion in financing for its bid for its much larger rival. According to Bernstein analysts, a sale for around 60% of India’s No. 3 drugmaker may be valued up to $7 billion, making it India’s largest pharma deal to date.
According to reports, Torrent has also been in talks with CVC Capital Partners and Bain Capital about becoming equity partners in a consortium and contributing up to $1.5 billion to the purchase.
According to insiders, Cipla’s founding family is eager to sell its 33.4% stake, and a bid for that amount would trigger an open offer for the remaining 26% under Indian regulations.
Reportedly, Apollo is considering purchasing a small portion of the Cipla founding family’s interest, but a final decision will depend on how talks with Torrent progress.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.